Supplement Firms Could Lighten FDA Inspection Load, Need Lighter Drug Preclusion Touch – CRN

CRN suggestion that FDA prioritize facility inspections on firms which haven’t been cleared in third-party audits apparently has support at agency. But FDA hasn’t been receptive to adjusting its policy on precluding from use as dietary ingredients any substance studied or approved as a drug.